Palisade Bio Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: PALI
Share price (5/22/26): $1.95
Market cap (5/22/26): $338 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from S-4/A 16 pages Contingent Value Rights Agreement

from 425 16 pages Contingent Value Rights Agreement

from 8-K 16 pages Contingent Value Rights Agreement

from 425 104 pages Agreement and Plan of Merger Among: Seneca Biopharma Inc.; Townsgate Acquisition Sub 1, Inc.; and Leading Biosciences, Inc. Dated as of December 16, 2020

from 8-K 104 pages Agreement and Plan of Merger Among: Seneca Biopharma Inc.; Townsgate Acquisition Sub 1, Inc.; and Leading Biosciences, Inc. Dated as of December 16, 2020